ESR1 and cancer: CARM1 was originally identified as a coactivator for steroid hormone receptors, including the estrogen receptor (ER), and was later shown to transactivate other cancer-relevant transcription factors including NF-κB, p53, and β-catenin via methyltransferase-dependent and-independent pathways [5].